What amount sold does ValCor Cath Inc. report in Form D filings?

The latest linked filings report $4.3M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was ValCor Cath Inc.'s most recent SEC filing?

ValCor Cath Inc.'s most recent Form D filing was on 2025-08-14.

How many investors does ValCor Cath Inc. have?

The most recent Form D filing lists 52 investor(s).

What type of securities does ValCor Cath Inc. offer?

ValCor Cath Inc.'s SEC Form D filings indicate equity offerings.

ValCor Cath Inc.

CIK: 0001979820·Biotechnology·OTTAWA HILLS, OH·Corporation·Founded 2023

Reported Sold

$4,250,000

Total Filings

Identified Offerings

Last Filed

Aug 14, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Aug 14, 2025Form D/A — Amendment

Reported sold: $4,250,000 · Target: $4,250,000

Rule 506(b)·52 investors

Changed: Reported amount sold, Offering target, Reported investors

Jun 8, 2023Form D — New notice

Reported sold: $1,074,981 · Target: $2,250,000

Rule 506(b)·11 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

50%

Latest reported sold across 1 identified offering

$4,250,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Howard Bobrow

Related Person

Appears on 2 filings

P. Kasi Ramanathan

Related Person

Appears on 2 filings

Eugene Jung

Related Person

Appears on 2 filings

Diane Chelsea

Related Person

Appears on 1 filing

Matthew Pollman

Related Person

Appears on 1 filing

Michael Bunker

Related Person

Appears on 1 filing

Gary Smith

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Aug 14, 2025	Amendment	$4,250,000	$4,250,000	52
Jun 8, 2023	New	$2,250,000	$1,074,981	11

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Autology, Inc.

Biotechnology

Offering target: $5,100,000

Filed Sep 30, 2026